Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,480 | -12,845 | -33,560 | -49,112 | -23,713 |
| Depreciation Amortization | 16 | 8 | 90 | 81 | 59 |
| Other Working Capital | 1,806 | 1,131 | 555 | -1,324 | 371 |
| Other Operating Activity | 5,890 | 5,595 | 10,180 | 32,986 | 13,137 |
| Operating Cash Flow | $-12,768 | $-6,111 | $-22,735 | $-17,369 | $-10,146 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,225 | 7,612 | 27,292 | 19,797 | 13,422 |
| Other Financing Activity | 0 | 0 | -8 | 0 | 0 |
| Financing Cash Flow | $11,225 | $7,612 | $27,284 | $19,797 | $13,422 |
| Exchange Rate Effect | -73 | -62 | 51 | -3 | 3 |
| Beginning Cash Position | 8,878 | 8,878 | 4,278 | 4,278 | 4,278 |
| End Cash Position | 7,262 | 10,317 | 8,878 | 6,703 | 7,557 |
| Net Cash Flow | $-1,616 | $1,439 | $4,600 | $2,425 | $3,279 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,768 | -6,111 | -22,735 | -17,369 | -10,146 |
| Free Cash Flow | -12,768 | -6,111 | -22,735 | -17,369 | -10,146 |